Colgate-Palmolive Co Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $21B+4.7% YoYTTM through 30 Jun 2026
Net Income $2B-29.5% YoYTTM through 30 Jun 2026
Free Cash Flow $3.9BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 60.4% |
| EBITDA Margin | 17.9% |
| Operating Margin | 14.9% |
| Net Margin | 9.7% |
Returns
12.1%ROA
26.1%ROIC
Balance Sheet Health
Debt / Equity37.87x
Current Ratio1.03x
Net Debt$7.6B
Cash & Equivalents$1.4B
Quality Metrics
Altman Z-Score6.70
Piotroski F-Score7 / 9
FCF Margin18.3%
Rule of 4020.0
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $20.4B
Diluted EPS$2.54TTMFY2025: $2.63
Dividend
$1.58Per share, FY20261.82%Yield-2.5%5-yr growth
Capital Allocation
R&D Spend$366M
Capex Intensity2.8%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Oral, Personal and Home Care | $15.8B | +1.0% | |
| Pet Nutrition | $4.6B | +2.9% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.